TC Biopharm (Holdings) Plc (TCBP)

NASDAQ: TCBP · IEX Real-Time Price · USD

0.854

-0.015 (-1.78%)

At close: Jul 19, 2024, 4:00 PM

0.830

-0.024 (-2.78%)

Pre-market: Jul 22, 2024, 6:42 AM EDT

TC Biopharm (Holdings) Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TCBP.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for TCBP.

Recommendation Trends

Rating	Jan '23	Feb '23	Mar '23
Strong Buy	2	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $1,800 → $1,400	Strong Buy	Maintains	$1,800 → $1,400	+163,892.03%	Apr 27, 2023
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $1,800	Strong Buy	Initiates	$1,800	+210,746.90%	Jan 26, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $50,000	Strong Buy	Initiates	$50,000	+5,856,758.38%	Mar 28, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

from -19.20

EPS Next Year

n/a

Year	2019	2020	2021	2022	2023
Revenue	3.43M	1.98M	1.98M	3.84M	-
Revenue Growth	-	-42.26%	-	94.30%	-
EPS	-340.00	-288.40	-695.20	-38.20	-19.20
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.